The global demand for Hormonal Contraception Market is presumed to reach the market size of nearly USD 28.8 BN by 2028 from USD 17.26 BN in 2021 with a CAGR of 7.2% under the study period 2022 - 2028.
Hormonal contraception is a drug used to regulate hormonal activity, such as birth control. Hormonal contraception comes in several forms and may contain estrogen and progesterone or solely progesterone. They inhibit conception by preventing the ovaries from releasing the eggs, weakening the uterine lining, or thickening the mucus in the cervix, all of which prevent sperm from reaching the egg. Hormonal contraceptives can be administered orally, injected or inserted under the skin, applied as a patch to the skin, or implanted in the uterus.
Market Dynamics
Hormonal contraception is becoming increasingly popular as it is thought to be more reliable. Several manufacturers are investing in R&D to produce better and more effective contraceptive options. The demand for hormonal contraception remains high to avoid unwanted pregnancy and other purposes, and the market is expected to rise in the future. Many nations are beginning to invest in it to meet the demand for population control. The increasing awareness of hormonal contraception is also helping to expand its market. However, the adverse effects of hormonal contraception may pose a threat to the product's commercial expansion. These hormonal contraception methods can potentially disrupt women's menstrual cycles. This downside of hormonal contraception may hamper market expansion.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hormonal contraception. The growth and trends of hormonal contraception industry provide a holistic approach to this study.
Market Segmentation
This section of the hormonal contraception market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Oral Contraceptive Pills
- Injectable Birth Control
- Emergency Contraceptive Pills
- Vaginal Rings
- Transdermal Patches
By Hormones
- Progestin-Only Contraceptive
- Combined Hormonal Contraceptive
By End User
- Hospitals
- Homecare Settings
- Gynaecology Centers
- Ambulatory Surgical Centers
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Hormonal Contraception market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Hormonal Contraception Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hormonal contraception market include Abbvie Inc., Bayer AG, Pfizer Inc, Agile Therapeutics, Pregna International Ltd., Lupin Pharmaceuticals Inc, Janssen Pharmaceuticals Inc., Teva Pharmaceuticals Industries Ltd., Afaxys Inc., Johnson & Johnson, Merck & Co Inc, Church & Dwight Co Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
